Review Article

You have full text access to this OnlineOpen article

Pediatric gastrointestinal stromal tumors and leiomyosarcoma

The St. Jude Children's Research Hospital experience and a review of the literature

  1. Monica S. Cypriano M.D.1,2,
  2. Jesse J. Jenkins M.D.3,4,
  3. Alberto S. Pappo M.D.1,2,†,
  4. Bhaskar N. Rao M.D.5,6,
  5. Najat C. Daw M.D.1,2,‡,*

Article first published online: 28 MAY 2004

DOI: 10.1002/cncr.20352

Issue

Cancer

Cancer

Volume 101, Issue 1, pages 39–50, 1 July 2004

Additional Information

How to Cite

Cypriano, M. S., Jenkins, J. J., Pappo, A. S., Rao, B. N. and Daw, N. C. (2004), Pediatric gastrointestinal stromal tumors and leiomyosarcoma. Cancer, 101: 39–50. doi: 10.1002/cncr.20352

Author Information

  1. 1

    Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee

  2. 2

    Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee

  3. 3

    Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee

  4. 4

    Department of Pathology, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee

  5. 5

    Department of Surgery, St. Jude Children's Research Hospital, Memphis, Tennessee

  6. 6

    Department of Surgery, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee

  1. †

    Division of Hematology-Oncology, University of Toronto/The Hospital for Sick Children, Toronto, Ontario, Canada

  1. ‡

    Fax: (901) 521-9005

*Department of Hematology-Oncology, Mail Stop 260, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105-2794

Publication History

  1. Issue published online: 18 JUN 2004
  2. Article first published online: 28 MAY 2004
  3. Manuscript Accepted: 15 APR 2004
  4. Manuscript Revised: 9 APR 2004
  5. Manuscript Received: 30 DEC 2003

Funded by

  • United States Public Health Service Cancer Center. Grant Number: CA-21765
  • Childhood Solid Tumor Program Project. Grant Number: CA-23099
  • American Lebanese Syrian Associated Charities (ALSAC)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (117K)

REFERENCES

  • 1
    Chan JK. Mesenchymal tumors of the gastrointestinal tract: a paradise for acronyms (STUMP, GIST, GANT, and now GIPACT), implication of c-kit in genesis, and yet another of the many emerging roles of the interstitial cell of Cajal in the pathogenesis of gastrointestinal diseases? Adv Anat Pathol. 1999; 6: 19–40.
  • 2
    Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol. 1983; 7: 507–519.
  • 3
    Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002; 33: 459–465.
  • 4
    Herrera GA, Pinto de Moraes H, Grizzle WE, Han SG. Malignant small bowel neoplasm of enteric plexus derivation (plexosarcoma). Light and electron microscopic study confirming the origin of the neoplasm. Dig Dis Sci. 1984; 29: 275–284.
  • 5
    Walker P, Dvorak AM. Gastrointestinal autonomic nerve (GAN) tumor. Ultrastructural evidence for a newly recognized entity. Arch Pathol Lab Med. 1986; 110: 309–316.
  • 6
    Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol. 1998; 152: 1259–1269.
  • 7
    Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol. 1998; 11: 728–734.
  • 8
    Rubin BP, Singer S, Tsao C, et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res. 2001; 61: 8118–8121.
  • 9
    Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998; 279: 577–580.
  • 10
    Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 2002; 347: 472–480.
  • 11
    Dagher R, Cohen M, Williams G, et al. Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors. Clin Cancer Res. 2002; 8: 3034–3038.
  • 12
    Berman J, O'Leary TJ. Gastrointestinal stromal tumor workshop. Hum Pathol. 2001; 32: 578–582.
  • 13
    Miser JS, Triche TJ, Kinsella TJ, Pritchard DJ. Other soft tissue sarcomas of childhood. In: PizzoPA, PoplackDG, editors. Principles and practice of pediatric oncology ( 3rd edition). Philadelphia: Lippincott-Raven, 1997: 865–888.
  • 14
    Gustafson P, Willen H, Baldetorp B, Ferno M, Akerman M, Rydholm A. Soft tissue leiomyosarcoma. A population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content. Cancer. 1992; 70: 114–119.
    Direct Link:
  • 15
    Kramer S, Meadows AT, Jarrett P, Evans AE. Incidence of childhood cancer: experience of a decade in a population-based registry. J Natl Cancer Inst. 1983; 70: 49–55.
  • 16
    Young JL, Miller RW. Incidence of malignant tumors in U.S. children. J Pediatr. 1975; 86: 254–258.
  • 17
    Harms D. Soft tissue sarcomas in the Kiel Pediatric Tumor Registry. Curr Top Pathol. 1995; 89: 31–45.
  • 18
    Perez-Atayde AR, Shamberger RC, Kozakewich HW. Neuroectodermal differentiation of the gastrointestinal tumors in the Carney triad. An ultrastructural and immunohistochemical study. Am J Surg Pathol. 1993; 17: 706–714.
  • 19
    Li P, Wei J, West AB, Perle M, Greco MA, Yang GC. Epithelioid gastrointestinal stromal tumor of the stomach with liver metastases in a 12-year-old girl: aspiration cytology and molecular study. Pediatr Dev Pathol. 2002; 5: 386–394.
  • 20
    Tortella BJ, Matthews JB, Antonioli DA, Dvorak AM, Silen W. Gastric autonomic nerve (GAN) tumor and extra-adrenal paraganglioma in Carney's triad. A common origin. Ann Surg. 1987; 205: 221–225.
  • 21
    Bates AW, Feakins RM, Scheimberg I. Congenital gastrointestinal stromal tumour is morphologically indistinguishable from the adult form, but does not express CD117 and carries a favourable prognosis. Histopathology. 2000; 37: 316–322.
    Direct Link:
  • 22
    Lauwers GY, Erlandson RA, Casper ES, Brennan MF, Woodruff JM. Gastrointestinal autonomic nerve tumors. A clinicopathological, immunohistochemical, and ultrastructural study of 12 cases. Am J Surg Pathol. 1993; 17: 887–897.
  • 23
    Kodet R, Snajdauf J, Smelhaus V. Gastrointestinal autonomic nerve tumor: a case report with electron microscopic and immunohistochemical analysis and review of the literature. Pediatr Pathol. 1994; 14: 1005–1016.
  • 24
    Kerr JZ, Hicks MJ, Nuchtern JG, et al. Gastrointestinal autonomic nerve tumors in the pediatric population: a report of four cases and a review of the literature. Cancer. 1999; 85: 220–230.
    Direct Link:
  • 25
    Varan A, Doganci T, Taskin M, Uner A, Varan B. Gastrointestinal autonomic nerve tumor: the youngest case reported in the literature. J Pediatr Gastroenterol Nutr. 2000; 31: 183–184.
  • 26
    Wu SS, Buchmiller TL, Close P, Gershman GB, Peng SK, French SW. Congenital gastrointestinal pacemaker cell tumor. Arch Pathol Lab Med. 1999; 123: 842–845.
  • 27
    Terada R, Ito S, Akama F, Kidogawa H, Ichikawa K, Ooe H. Clinical and histopathological features of colonic stromal tumor in a child. J Gastroenterol. 2000; 35: 456–459.
  • 28
    Shenoy MU, Singh SJ, Robson K, Stewart RJ. Gastrointestinal stromal tumor: a rare cause of neonatal intestinal obstruction. Med Pediatr Oncol. 2000; 34: 70–71.
    Direct Link:
  • 29
    Johnston DL, Olson JM, Benjamin DR. Gastrointestinal stromal tumor in a patient with previous neuroblastoma. J Pediatr Hematol Oncol. 2001; 23: 255–256.
  • 30
    O'Shea PA. Myogenic tumors of soft tissue. In: CoffinCM, DehnerLP, O'SheaPA, editors. Pediatric soft tissue tumors: a clinical, pathological, and therapeutic approach. Philadelphia: Lippincott Williams & Wilkins, 2002: 214–253.
  • 31
    de Saint Aubain Somerhausen N, Fletcher CD. Leiomyosarcoma of soft tissue in children: clinicopathologic analysis of 20 cases. Am J Surg Pathol. 1999; 23: 755–763.
  • 32
    Parham DM, Webber BL, Jenkins JJ III, Cantor AB, Maurer HM. Nonrhabdomyosarcomatous soft tissue sarcomas of childhood: formulation of a simplified system for grading. Mod Pathol. 1995; 8: 705–710.
  • 33
    Maurer HM, Beltangady M, Gehan EA, et al. The Intergroup Rhabdomyosarcoma Study-I. A final report. Cancer. 1988; 61: 209–220.
    Direct Link:
  • 34
    HarmerMH, editor. TNM classification of pediatric tumors. Geneva: International Union Against Cancer, 1982.
  • 35
    Joensuu H, Fletcher C, Dimitrijevic S, Silberman S, Roberts P, Demetri G. Management of malignant gastrointestinal stromal tumours. Lancet Oncol. 2002; 3: 655–664.
  • 36
    DeMatteo RP, Heinrich MC, El-Rifai WM, Demetri G. Clinical management of gastrointestinal stromal tumors: before and after STI-571. Hum Pathol. 2002; 33: 466–477.
  • 37
    Reith JD, Goldblum JR, Lyles RH, Weiss SW. Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol. 2000; 13: 577–585.
  • 38
    Miettinen M, Monihan JM, Sarlomo-Rikala M, et al. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol. 1999; 23: 1109–1118.
  • 39
    Ortiz-Hidalgo C, de Leon BB, Albores-Saavedra J. Stromal tumor of the gallbladder with phenotype of interstitial cells of Cajal: a previously unrecognized neoplasm. Am J Surg Pathol. 2000; 24: 1420–1423.
  • 40
    Lasota J, Carlson JA, Miettinen M. Spindle cell tumor of urinary bladder serosa with phenotypic and genotypic features of gastrointestinal stromal tumor. Arch Pathol Lab Med. 2000; 124: 894–897.
  • 41
    Miettinen M, El-Rifai W, Sobin HL, Lasota J. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol. 2002; 33: 478–483.
  • 42
    Ernst SI, Hubbs AE, Przygodzki RM, Emory TS, Sobin LH, O'Leary TJ. KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors. Lab Invest. 1998; 78: 1633–1636.
  • 43
    Lasota J, Jasinski M, Sarlomo-Rikala M, Miettinen M. Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol. 1999; 154: 53–60.
  • 44
    DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000; 231: 51–58.
  • 45
    Van Glabbeke M, van Oosterom AT, Oosterhuis JW, et al. Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens—a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group study. J Clin Oncol. 1999; 17: 150–157.
  • 46
    Trent JC, Beach J, Burgess MA, et al. A two-arm Phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas. Cancer. 2003; 98: 2693–2699.
    Direct Link:
  • 47
    von Mehren M, Blanke C, Joensuu H, et al. High incidence of durable responses induced by imatinib mesylate (Gleevec) in patients with unresectable and metastatic gastrointestinal stromal tumors (GISTs) [abstract]. Proc Am Soc Clin Oncol. 2002; 21: 403a.
  • 48
    Benjamin R, Rankin C, Fletcher C, et al. Phase III dose-randomized study of imatinib mesylate (STI571) for GIST: Intergroup S0033 early results[abstract]. Proc Am Soc Clin Oncol. 2003; 22: 814.
  • 49
    Heinrich M, Corless C, Blanke C, et al. KIT mutational status predicts clinical response to STI571 in patients with metastatic gastrointestinal stromal tumors (GISTs) [abstract]. Proc Am Soc Clin Oncol. 2002; 21: 2a.
  • 50
    Heinrich MC, Blanke CD, Druker BJ, Corless CL. Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J Clin Oncol. 2002; 20: 1692–1703.
  • 51
    Clary BM, DeMatteo RP, Lewis JJ, Leung D, Brennan MF. Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison. Ann Surg Oncol. 2001; 8: 290–299.
  • 52
    Crosby JA, Catton CN, Davis A, et al. Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database. Ann Surg Oncol. 2001; 8: 50–59.
  • 53
    Craft AW, Malcolm AJ, Farndon JR. Intestinal leiomyosarcoma following treatment of osteosarcoma in a teenage girl. Pediatr Hematol Oncol. 1989; 6: 341–348.
  • 54
    O'Sullivan SG, Das NL, Ferraro E. Primary ovarian leiomyosarcoma in an adolescent following radiation for medulloblastoma. Pediatr Radiol. 1998; 28: 468–470.
  • 55
    Meadows AT, Silber J. Delayed consequences of therapy for childhood cancer. CA Cancer J Clin. 1985; 35: 271–286.
    Direct Link:
  • 56
    Brichard B, Vermylen C, Gosseye S, Otte JB, Cornu G. Smooth muscle tumor developing in an immunocompromised child after therapy for leukemia. J Pediatr Hematol Oncol. 2001; 23: 139–141.
  • 57
    Lee ES, Locker J, Nalesnik M, et al. The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med. 1995; 332: 19–25.
  • 58
    Ha C, Haller JO, Rollins NK. Smooth muscle tumors in immunocompromised (HIV negative) children. Pediatr Radiol. 1993; 23: 413–414.
  • 59
    Coskun M, Aydingoz U, Tacal T, Ariyurek M, Demirkazik F, Oguzkurt L. CT and MR imaging of splenic leiomyoma in a child with ataxia telangiectasia. Pediatr Radiol. 1995; 25: 45–47.
  • 60
    Mierau GW, Greffe BS, Weeks DA. Primary leiomyosarcoma of brain in an adolescent with common variable immunodeficiency syndrome. Ultrastruct Pathol. 1997; 21: 301–305.
  • 61
    Granovsky MO, Mueller BU, Nicholson HS, Rosenberg PS, Rabkin CS. Cancer in human immunodeficiency virus-infected children: a case series from the Children's Cancer Group and the National Cancer Institute. J Clin Oncol. 1998; 16: 1729–1735.
  • 62
    Biggar RJ, Frisch M, Goedert JJ. Risk of cancer in children with AIDS. AIDS-Cancer Match Registry Study Group. JAMA. 2000; 284: 205–209.
  • 63
    McLoughlin LC, Nord KS, Joshi VV, DiCarlo FJ, Kane MJ. Disseminated leiomyosarcoma in a child with acquired immune deficiency syndrome. Cancer. 1991; 67: 2618–2621.
    Direct Link:
  • 64
    Chadwick EG, Connor EJ, Hanson IC, et al. Tumors of smooth-muscle origin in HIV-infected children. JAMA. 1990; 263: 3182–3184.
  • 65
    Jenson HB, Leach CT, McClain KL, et al. Benign and malignant smooth muscle tumors containing Epstein-Barr virus in children with AIDS. Leuk Lymphoma. 1997; 27: 303–314.
  • 66
    Hill MA, Araya JC, Eckert MW, Gillespie AT, Hunt JD, Levine EA. Tumor specific Epstein-Barr virus infection is not associated with leiomyosarcoma in human immunodeficiency virus negative individuals. Cancer. 1997; 80: 204–210.
    Direct Link:
  • 67
    Ferrari A, Bisogno G, Casanova M, et al. Childhood leiomyosarcoma: a report from the Soft Tissue Sarcoma Italian Cooperative Group. Ann Oncol. 2001; 12: 1163–1168.
  • 68
    Lack EE. Leiomyosarcomas in childhood: a clinical and pathologic study of 10 cases. Pediatr Pathol. 1986; 6: 181–197.
  • 69
    Hwang ES, Gerald W, Wollner N, Meyers P, La Quaglia MP. Leiomyosarcoma in childhood and adolescence. Ann Surg Oncol. 1997; 4: 223–227.
  • 70
    Swanson PE, Wick MR, Dehner LP. Leiomyosarcoma of somatic soft tissues in childhood: an immunohistochemical analysis of six cases with ultrastructural correlation. Hum Pathol. 1991; 22: 569–577.
  • 71
    Plaat BE, Hollema H, Molenaar WM, et al. Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins. J Clin Oncol. 2000; 18: 3211–3220.
  • 72
    Wile AG, Evans HL, Romsdahl MM. Leiomyosarcoma of soft tissue: a clinicopathologic study. Cancer. 1981; 48: 1022–1032.
    Direct Link:
  • 73
    Hashimoto H, Daimaru Y, Tsuneyoshi M, Enjoji M. Leiomyosarcoma of the external soft tissues. A clinicopathologic, immunohistochemical, and electron microscopic study. Cancer. 1986; 57: 2077–2088.
    Direct Link:
  • 74
    Yannopoulos K, Stout AP. Smooth muscle tumors in children. Cancer. 1962; 15: 958–971.
    Direct Link:
  • 75
    Wilkinson N, Rollason TP. Recent advances in the pathology of smooth muscle tumours of the uterus. Histopathology. 2001; 39: 331–341.
    Direct Link:
  • 76
    Edmonson JH, Marks RS, Buckner JC, Mahoney MR. Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas. Cancer Invest. 2002; 20: 605–612.
  • 77
    van Oosterom AT, Mouridsen HT, Nielsen OS, et al. Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients. Eur J Cancer. 2002; 38: 2397–2406.
  • 78
    Sutton G, Blessing JA, Malfetano JH. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol. 1996; 62: 226–229.
  • 79
    Ferrer F, Sabater S, Farrus B, et al. Impact of radiotherapy on local control and survival in uterine sarcomas: a retrospective study from the Grup Oncologic Catala-Occita. Int J Radiat Oncol Biol Phys. 1999; 44: 47–52.
View Full Article (HTML) Get PDF (117K)